Immuno-Biological Laboratories (IBL) announces contract with Astellas on production of human fibrinogen in recombinant silkworms

The test plant of IBL in Gunma Prefecture is registered for such kind of experiments and has produced a number of recombinant proteins from transgenic silkworms already. The Astellas contract starts on March 31, 2015.

IBL news release, March 31, 2015

Most popular posts: